Clinical case of long-term use of atezolizumab and bevacizumab in the first-line treatment of recurrence of non-small cell lung cancer

Por O. A. Rozonova, I. Y. Bazaeva, V. A. Gorbunova, E. V. Artamonova
Publicado em 2020-07-01